Centro de Investigaciones Biomédicas (CIB)

The Center for Biomedical Research (CIB for its initials in Spanish) at UNAB was created in March 2010 in a joined effort by the Faculty of Biological Sciences and the Faculty of Medicine to promote multidisciplinary basic and translational biomedical research. The CIB is focused on understanding basic cellular and molecular mechanisms behind devastating diseases including osteoporosis and the brain disorders Alzheimer, autism and ALS.

Currently, the CIB consists of six research groups led by Dr. Martin Montecino, Director of CIB, Dr. Giancarlo De Ferrari,  Dr. Jimmy Stehberg, Dr. Brigitte van Zundert, Dr. Lorena Varela-Nallar and Dr. Álvaro Elorza. The expertise of these investigators includes molecular and cellular biology, genetics, biochemistry, fluorescent techniques, electrophysiology and behavioural studies. The investigators of CIB maintain a wide platform of international scientific collaborators with investigators at foreign institutions such as University of Massachusetts (UMASS), Massachusetts Institute of Technology (MIT), University of Washington, National Institute of Health (NIH), Emory University and University of Groningen.

The CIB has a strong commitment to developing basic research capacities. Currently, we are training many young scientists including postdoctoral fellows, PhD students and a large number of undergraduate students in fields such as Biochemistry and Biotechnology.

The research at CIB is funded by national agencies, including FONDAP and FONDECYT, as well as by international agencies, like NIH and ALS-Therapy Alliance.